PIK3C2A has been implicated in a number of cancer pathophysiological pathways due to its ability to catalyze the phosphorylation of lipids phosphatidylinositol (PI) into PI (3)P and PI (4)P into PI (3, 4) P2 (11). This evidence concerns the gene PIK3C2A and cancer.